NCT00590772View on ClinicalTrials.gov

The Role of Montelukast in Rhinitis and Sleep

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

montelukast

10 mg po each day (compared to placebo for 2 weeks)

DRUG

placebo

placebo for 2 weeks

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Penn State University

OTHER

NCT00590772 - The Role of Montelukast in Rhinitis and Sleep | Biotech Hunter | Biotech Hunter